miRNA-101 was found to target different pathways that promote breast cancer cell apoptosis by inhibiting the expression of Jak2, EYA1 and SOX2 acting as a potential therapeutic target in breast cancer [10]. This evidence concerns the gene SOX2 and breast cancer.